The FDA has approved changes to the drug label of the anti-seizure drug ezogabine (Potiga), underscoring risks of abnormalities to the retina in the eye, potential vision loss, and skin discoloration-all of which may become permanent.
Optical coherence tomography angiography can detect microcirculatory disturbances during acute attacks.
Among a subset of patients in the phase IV PALADIN study, there was improved visual acuity, improved macular thickness, and reduced treatment burden among patients treated with the intravitreal fluocinolone acetonide 0.2 µg (Iluvien implant) for DME.
A study has revealed that a budgetary saving per treated patient with the fluocinolone acetonide implant (Iluvien) versus ranibizumab (Lucentis) could lead to a significant cost-saving to NHS England.
Preliminary research has shown that ataluren is effective in overriding the nonsense mutation in choroideremia patients, however, further research is needed.
A retina specialist discusses impressions and key take away points from patient case.
Investigational pipeline provides promise for an unmet need.
The prevalence of visual impairment and blindness caused by diabetic retinopathy is increasing worldwide. Early recognition, perhaps via a screening programme, and timely management would be of benefit.
The prevalence of visual impairment and blindness caused by diabetic retinopathy is increasing worldwide. Early recognition, perhaps via a screening programme, and timely management would be of benefit.
Study aims to identify methodology for least amount of variation, greatest test-retest reliability
Study aims to identify methodology for least amount of variation, greatest test-retest reliability
Study aims to identify methodology for least amount of variation, greatest test-retest reliability
Study aims to identify methodology for least amount of variation, greatest test-retest reliability
Study aims to identify methodology for least amount of variation, greatest test-retest reliability
David A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.
Study aims to identify methodology for least amount of variation, greatest test-retest reliability
Study aims to identify methodology for least amount of variation, greatest test-retest reliability
Study aims to identify methodology for least amount of variation, greatest test-retest reliability
Combination therapy benefits from laser in the mix for DME, other conditions
Patients tolerate therapy well; high safety profile allows re-treatment as necessary